NDC 50474-780 – Bimzelx

Bimekizumab 160 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC50474-780

Product details

Brand name
Bimzelx
Generic name
Bimekizumab
Labeler
UCB, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761151
Marketed since
October 17, 2023
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Bimzelx →

Package NDC codes (2)

Package NDCDescriptionSince
50474-780-781 SYRINGE, GLASS in 1 CARTON (50474-780-78) / 1 mL in 1 SYRINGE, GLASSOct 1, 2024
50474-780-792 SYRINGE, GLASS in 1 CARTON (50474-780-79) / 1 mL in 1 SYRINGE, GLASSOct 17, 2023

Other Bimzelx products